Evidence map›Paper›PMID 36282498›Full record

ArticleJAMA network open2022

Menstrual Cycle Regularity and Length Across the Reproductive Lifespan and Risk of Cardiovascular Disease.

Yi-Xin Wang, Jennifer J Stuart, Janet W Rich-Edwards, Stacey A Missmer, Kathryn M Rexrode, Leslie V Farland, Kenneth J Mukamal, Scott M Nelson, Caren G Solomon, Abigail Fraser and 1 more

Open access · goldAbstract read
In one paragraph

Article in JAMA network open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Stable angina in young women.European heart journal · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. The menstrual cycle is a vital sign across the lifespan.The Lancet. Obstetrics, gynaecology, & women's health · 2025
    Article
  9. Article
  10. Tailoring cardiovascular risk prediction to females.The Journal of endocrinology · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Time to cycle regularity and health risks.Current opinion in endocrinology, diabetes, and obesity · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Yi-Xin WangDepartment of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Jennifer J StuartDivision of Women's Health, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Janet W Rich-EdwardsDivision of Women's Health, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Stacey A MissmerDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Kathryn M RexrodeDivision of Women's Health, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Leslie V FarlandDepartment of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, Tucson, Arizona.
Kenneth J MukamalDivision of General Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.
Scott M NelsonSchool of Medicine, University of Glasgow, Glasgow, United Kingdom.
Caren G SolomonDivision of Women's Health, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Abigail FraserDepartment of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
Jorge E ChavarroDepartment of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Harvard University · USBrigham and Women's Hospital · USBeth Israel Deaconess Medical Center · USUniversity of Bristol · GBUniversity of Glasgow · GB

Funding

Risk Factors for Ischemic Stroke in WomenR01HL088521 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI REXRODE, KATHRYN M · 2008 to 2025
$9.9M
Female-Specific Risk Factors for CVD: The Impact of Adverse Pregnancy Outcomes on Subsequent Mental Health and CVD RiskK01HL159281 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI STUART, JENNIFER JACQUELINE · 2022 to 2024
$348k
NHLBI NIH HHS K01 HL159281NHLBI NIH HHS R01 HL088521
6 · The paper itself

Abstract

Importance: Menstrual cycle characteristics may be associated with an increased risk of cardiovascular disease (CVD). However, existing studies are limited, and few have explored the mediating role of established CVD risk factors. Objective: To explore the associations of menstrual cycle characteristics across the reproductive lifespan with the risk of CVD and to what extent these associations were mediated by hypercholesterolemia, chronic hypertension, and type 2 diabetes. Design, Setting, and Participants: This cohort study prospectively followed Nurses' Health Study II participants between 1993 and 2017 who reported menstrual cycle regularity and length for ages 14 to 17 years and 18 to 22 years at enrollment in 1989 and updated current cycle characteristics in 1993 (at ages 29 to 46 years). Data analysis was performed from October 1, 2019, to January 1, 2022. Exposures: Menstrual cycle regularity and length across the reproductive lifespan. Main Outcomes and Measures: Incident CVD events of interest, including fatal and nonfatal coronary heart disease (CHD; myocardial infarction [MI] or coronary revascularization) and stroke. Results: A total of 80 630 Nurses' Health Study II participants were included in the analysis, with a mean (SD) age of 37.7 (4.6) years and body mass index of 25.1 (5.6) at baseline. Over 24 years of prospective follow-up, 1816 women developed their first CVD event. Multivariable Cox proportional hazards models showed that, compared with women reporting very regular cycles at the same ages, women who had irregular cycles or no periods at ages 14 to 17, 18 to 22, or 29 to 46 years had hazard ratios for CVD of 1.15 (95% CI, 0.99-1.34), 1.36 (95% CI, 1.06-1.75), and 1.40 (95% CI, 1.14-1.71), respectively. Similarly, compared with women reporting a cycle length of 26 to 31 days, women reporting a cycle length 40 days or more or a cycle too irregular to estimate from ages 18 to 22 or 29 to 46 years had hazard ratios for CVD of 1.44 (95% CI, 1.13-1.84) and 1.30 (95% CI, 1.09-1.57), respectively. Mediation analyses showed that subsequent development of hypercholesteremia, chronic hypertension, and type 2 diabetes only explained 5.4% to 13.5% of the observed associations. Conclusions and Relevance: In this cohort study, both irregular and long menstrual cycles were associated with increased rates of CVD, which persisted even after accounting for subsequently established CVD risk factors.

Indexed as

Cardiovascular DiseasesDiabetes Mellitus, Type 2HypercholesterolemiaHypertensionAdolescentAdultCohort StudiesFemaleHumansLongevityMenstrual CycleMiddle AgedProspective StudiesRisk FactorsYoung Adult

Identifiers

PMID36282498
PMCPMC9597395
OpenAlexW4307405502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.